JAK1 inhibitor: A promising option for patients with pigmented purpuric dermatoses

J Eur Acad Dermatol Venereol. 2024 May;38(5):e388-e390. doi: 10.1111/jdv.19616. Epub 2023 Nov 16.

Authors

Shan Cao¹, Yongxia Liu¹, Shengli Chen¹, Qing Zhao¹, Xiaotong Xue¹, Pengcheng Huai¹, Furen Zhang¹

Affiliation

¹ Shandong Provincial Hospital for Skin Diseases & Shandong Provincial, Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

PMID: 37908169
DOI: 10.1111/jdv.19616

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Female
Humans
Janus Kinase 1* / antagonists & inhibitors
Janus Kinase Inhibitors / therapeutic use
Male
Middle Aged
Pigmentation Disorders* / drug therapy
Purpura / drug therapy

Substances

Janus Kinase 1
JAK1 protein, human
Janus Kinase Inhibitors

Supplementary concepts

Pigmented purpuric eruption